Skip to content

A Natural Approach to Eyelid Swelling-Combining Leech Therapy and Herbal Paste

Combined effect of Jalaukavacharana and Mukkadi Bidalaka in Blepharitis in the age group of 20-60 years: A pre-post interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091169
Enrollment
32
Registered
2025-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H010- Blepharitis

Interventions

None listed

Sponsors

Dr Dakh Pallavi Vasantrao
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects in the age group of 20 to 60 years, irrespective of gender, diagnosed with blepharitis. 2. Subjects willing to give written informed consent. 3. Subjects included in the study must have: a) At least one of the following symptoms: itching, redness, burning sensation, or swelling of the lid margin, along with b) At least one of the following signs: presence of yellow crust at the root of cilia of lid margin or presence of white dandruff-like scales.

Exclusion criteria

Exclusion criteria: 1. Subjects with any other acute or active inflammatory ocular pathology, eyelid or eyelash anomaly , glaucoma, or ocular hypertension. 2. History of ocular surgery or trauma within the last two months. 3. Subjects with any systemic conditions such as diabetes mellitus, cardiovascular disorders, autoimmune diseases, or bleeding disorders. 4. Subjects currently using systemic medications such as steroids, immunosuppressants, or anticoagulants. 5. Use of topical corticosteroids or topical ophthalmic medications within the past one month. 6. Subjects diagnosed with parasitic blepharitis or posterior blepharitis.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be measured using the grading scale of subjective parameters and objective parameters assessed with slit lamp examination o Itching o Burning sensation o Photophobia o Watering of eyes o Erythema of lid margin o Oedema of eyelid o Falling of eyelashes o Presence of scales / CrustsTimepoint: 0th 7th 14th and 21st day

Secondary

MeasureTime frame
The sustained effect of the drug will be assessed by evaluating any worsening of the grading of signs and symptoms during any of the follow-up visitsTimepoint: 0th 7th 14th and 21st day

Countries

India

Contacts

Public ContactDr Ambili K

Government Ayurveda College,Kannur

amlikavinal@gmail.com8590403936

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026